Series C startups in Switzerland
Updated 16 Nov 2026
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| SWISSto12 | Renens | Series C | $70.0M | 2026-07-16 |
| L.E.S.S. | Renens | Series C | $22.0M | 2026-02-26 |
| Neural Concept | Lausanne | Series C | $100.0M | 2025-12-18 |
| Cutiss | Zürich | Series C | $38.8M | 2025-09-10 |
| Meteomatics | Saint Gallen | Series C | $22.0M | 2025-01-29 |
| Sygnum | Zürich | Series C | $58.0M | 2025-01-14 |
| Numab | Wädenswil | Series C | $54.8M | 2025-01-09 |
| ImmunOs Therapeutics | Schlieren | Series C | $11.0M | 2024-09-17 |
8 rows of the CSV in 5 of its 18 columns.
- The 47 series c startups in Switzerland have raised $2.0B in total.
- 3 of them closed their most recent round in the last 12 months, $191.9M combined.
- The largest of those rounds is Neural Concept's $100.0M Series C, dated December 2025.
- The most recent is SWISSto12's $70.0M Series C on 16 July 2026.
- Venture Kick is an investor in 7 of them, more than any other fund.
- Biotech is the most common sector, with 20 companies (43%).
- 2% were founded in 2020 or later; the median founding year is 2012.
- The most common team size is 11 to 50 employees (36% of companies with a recorded size).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
22 of 47| Company | What they do | Sector | City | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| SWISSto12 | SWISSto12 designs, manufactures, and integrates radio frequency products for commercial and government customers. | Hardware | Renens | Series C | $70.0M | 2026-07-16 | $202.3M | Venture Kick, UBS, Swisscom Ventures +1 | 251 to 500 | 2011 |
| Neural Concept | Neural Concept offers an intelligence platform that uses 3D deep learning to redesign engineering products. | Artificial intelligence | Lausanne | Series C | $100.0M | 2025-12-18 | $136.8M | HTGF (High-Tech Gruenderfonds), Venture Kick, Alven +2 | 51 to 100 | 2019 |
| Cutiss | Cutiss is a life science company that produces regenerative medicine and engineers skin tissue. | Biotech | Zürich | Series C | $38.8M | 2025-09-10 | $94.6M | Innosuisse | 11 to 50 | 2017 |
| Meteomatics | Meteomatics offers curated IT solutions and business intelligence for the weather, energy, and trading industries. | Software | Saint Gallen | Series C | $22.0M | 2025-01-29 | $36.0M | Lockheed Martin Ventures, FortyOne Group, Alantra +1 | 101 to 250 | 2012 |
| Sygnum | Sygnum is a digital asset banking group that enables professional and institutional investors to invest in digital assets. | Fintech | Zürich | Series C | $58.0M | 2025-01-14 | $188.0M | Swiss Founders Fund, Wemade, Azimut Holding +1 | 251 to 500 | 2017 |
| ImmunOs Therapeutics | ImmunOs Therapeutics is a clinical-stage biotechnology company. | Biotech | Schlieren | Series C | $11.0M | 2024-09-17 | Lightspeed Venture Partners, Innosuisse, Mission BioCapital +1 | 11 to 50 | 2014 | |
| H55 | H55 develops certified technology to make aviation clean, quiet, efficient, affordable and autonomous. | Hardware | Sion | Series C | $22.6M | 2024-07-24 | Government of Canada, RTX Ventures, +ND Capital +2 | 101 to 250 | 2015 | |
| Asceneuron | Asceneuron develops therapeutics for orphan tauopathies and Alzheimer's disease. | Biotech | Lausanne | Series C | $100.0M | 2024-07-16 | OrbiMed, Novo Holdings, EQT Life Sciences +1 | 1 to 10 | 2012 | |
| Alpian | Alpian offers banking, personal wealth management, and tailored investment products in one app. | Fintech | Geneva | Series C | $83.7M | 2024-05-08 | $134.9M | REYL Group | 51 to 100 | 2019 |
| Memo Therapeutics | Memo Therapeutics conducts biotechnology research in antibody discovery and immune repertoire analysis. | Biotech | Schlieren | Series C | $22.0M | 2024-05-07 | $108.8M | Verve Ventures, Kurma Partners, Pureos Bioventures +1 | 11 to 50 | 2012 |
| Pexapark | Pexapark provides software and advisory services for renewable energy sales through an energy investment platform. | Energy | Schlieren | Series C | $21.1M | 2023-09-26 | $41.8M | SAP.iO, Titanium Ventures, Swisscom Ventures | 101 to 250 | 2017 |
| Anoma | Anoma builds a privacy-preserving protocol for decentralized counterparty discovery and multi-chain atomic settlement. | Software | Zug | Series C | $25.0M | 2023-05-30 | Polychain, MH Ventures, Lemniscap | 11 to 50 | 2021 | |
| Wire | Wire provides an encrypted messaging app for enterprise and government customers. | Cybersecurity | Zug | Series C | $24.8M | 2022-08-11 | UVC Partners, One Way Ventures, Cipio Partners +2 | 51 to 100 | 2012 | |
| AMINA Bank AG | AMINA Bank AG is a regulated crypto bank bridging digital and traditional assets. | Fintech | Zug | Series C | $120.3M | 2022-01-12 | Alameda Research, Antalpha, Gate Ventures | 101 to 250 | 2018 | |
| Frontify | Frontify provides a cloud-based brand management platform for brand creators and collaborators. | Software | Saint Gallen | Series C | $49.9M | 2021-09-27 | $80.5M | EQT Ventures, SICTIC, Blossom Capital +2 | 251 to 500 | 2013 |
| NBE-Therapeutics | NBE-Therapeutics develops oncology treatments for cancer patients. | Biotech | Basel | Series C | $22.0M | 2020-01-10 | $65.7M | Novo Holdings, Boehringer Ingelheim Venture Fund, PPF Group | 11 to 50 | 2012 |
| dacadoo | dacadoo offers digital lifestyle solutions through mobile apps from its base in Switzerland. | Biotech | Zürich | Series C | $71.1M | 2019-12-13 | Samsung Ventures | 51 to 100 | 2010 | |
| WayRay | WayRay is a deep tech company working in holography, optics, and lasers for content-driven mobility. | Hardware | Zürich | Series C | $80.0M | 2018-09-18 | China Merchants Venture Capital, Porsche Ventures | 101 to 250 | 2012 | |
| Andrew Alliance | Andrew Alliance is a Swiss pioneer in robotics for the life sciences sector. | Artificial intelligence | Geneva | Series C | $14.0M | 2018-06-12 | Venture Kick, Omega Funds, Rancilio Cube Sicaf | 11 to 50 | 2011 | |
| Endosense | Endosense develops medical technology that improves the reproducibility of catheter ablation for cardiac arrhythmias. | Biotech | Geneva | Series C | $41.2M | 2013-11-27 | 3i Group, VI Partners, Andera Partners +2 | 51 to 100 | 2003 | |
| Viroblock | Viroblock is a Swiss company developing antiviral technology for air filtration products. | Biotech | Geneva | Series C | $4.5M | 2012-02-14 | $4.5M | StartAngels Network, BlueOcean Ventures | 1 to 10 | 2005 |
| Synosia Therapeutics | Synosia Therapeutics develops and commercializes products for unmet needs in psychiatry and neurology. | Biotech | Basel | Series C | $30.0M | 2010-10-12 | $94.0M | Novo Holdings, Versant Ventures, 5AM Ventures +2 | 1 to 10 | 2006 |
Table 1. Series C startups in Switzerland: the 22 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 47.
Largest rounds
Last 12 months| # | Company | What they do | Sector | City | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Neural Concept | Neural Concept offers an intelligence platform that uses 3D deep learning to redesign engineering products. | Artificial intelligence | Lausanne | Series C | $100.0M | 2025-12-18 | $136.8M | HTGF (High-Tech Gruenderfonds), Venture Kick, Alven +2 | 51 to 100 | 2019 |
| 2 | SWISSto12 | SWISSto12 designs, manufactures, and integrates radio frequency products for commercial and government customers. | Hardware | Renens | Series C | $70.0M | 2026-07-16 | $202.3M | Venture Kick, UBS, Swisscom Ventures +1 | 251 to 500 | 2011 |
Table 2. Series C startups in Switzerland: the 2 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | Venture Kick | Startup incubator | Schlieren, Switzerland | 7 | 15% | 3 | SWISSto12, L.E.S.S., Neural Concept |
| 2 | Swisscom Ventures | Venture capital firm | Zürich, Switzerland | 4 | 9% | 1 | SWISSto12 |
| 3 | VI Partners | Venture capital firm | Altendorf, Switzerland | 3 | 6% | 1 | L.E.S.S. |
| 4 | Novo Holdings | Corporate venture arm | Hellerup, Denmark | 3 | 6% | ||
| 5 | StartAngels Network | Angel group | Zürich, Switzerland | 3 | 6% | ||
| 6 | Foundation for Innovation and Technology (FIT) | Entrepreneurship program | Lausanne, Switzerland | 2 | 4% | 1 | L.E.S.S. |
| 7 | Innosuisse | Government investment office | Berne, Switzerland | 2 | 4% | ||
| 8 | FortyOne Group | Private equity firm | Saint Gallen, Switzerland | 2 | 4% | ||
| 9 | BlackRock | Investment bank | New York, United States | 2 | 4% | ||
| 10 | TR Invest | Private equity firm | Tafers, Switzerland | 2 | 4% | ||
| 11 | BlueOcean Ventures | Venture capital firm | Plan-les-ouates, Switzerland | 2 | 4% | ||
| 12 | UBS | Corporate venture arm | Zürich, Switzerland | 1 | 2% | 1 | SWISSto12 |
| 13 | CNB Capital | Venture capital firm | Vienna, Austria | 1 | 2% | 1 | SWISSto12 |
| 14 | D. E. Shaw & Co. | Private equity firm | New York, United States | 1 | 2% | 1 | Neural Concept |
| 15 | Alven | Venture capital firm | Paris, France | 1 | 2% | 1 | Neural Concept |
Table 3. Series C startups in Switzerland: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
| Sectors | Companies | Share | Total raised |
|---|---|---|---|
| Biotech | 20 | 43% | $1.1B |
| Health care | 19 | 40% | $1.1B |
| Software | 18 | 38% | $523.2M |
| Hardware | 12 | 26% | $242.4M |
| Fintech | 6 | 13% | $322.9M |
| Artificial intelligence | 3 | 6% | $136.8M |
| Cybersecurity | 2 | 4% | |
| Energy | 1 | 2% | $41.8M |
| Commerce | 1 | 2% |
Table 4. Series C startups in Switzerland by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
| Funding stage | Companies | Share | Median last round |
|---|---|---|---|
| Series C | 47 | 100% | $25.0M |
Table 5. Series C startups in Switzerland by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Cities
| Cities | Companies | Share |
|---|---|---|
| Zürich | 6 | 13% |
| Geneva | 5 | 11% |
| Zug | 5 | 11% |
| Lausanne | 4 | 9% |
| Schlieren | 4 | 9% |
| Basel | 3 | 6% |
| Renens | 2 | 4% |
| Saint Gallen | 2 | 4% |
| Wädenswil | 2 | 4% |
| Sion | 1 | 2% |
| Allschwil | 1 | 2% |
| Fribourg | 1 | 2% |
Table 6. Series C startups in Switzerland by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| July 2026 | 1 | 33% | $70.0M |
| February 2026 | 1 | 33% | $22.0M |
| December 2025 | 1 | 33% | $100.0M |
Table 7. Series C startups in Switzerland: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 2 | 4% | $91.9M |
| 2025 | 5 | 11% | $273.6M |
| 2024 | 7 | 15% | $368.8M |
| 2023 | 3 | 6% | $72.1M |
| 2022 | 4 | 9% | $147.3M |
| 2021 | 3 | 6% | $82.9M |
Table 8. Series C startups in Switzerland by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2020 to 2022 | 1 | 2% |
| 2015 to 2019 | 11 | 23% |
| 2010 to 2014 | 22 | 47% |
| Before 2010 | 13 | 28% |
Table 9. Series C startups in Switzerland by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 1 to 10 | 9 | 19% |
| 11 to 50 | 17 | 36% |
| 51 to 100 | 11 | 23% |
| 101 to 250 | 6 | 13% |
| 251 to 500 | 4 | 9% |
Table 10. Series C startups in Switzerland by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when its most recent funding round is Series C and its headquarters is in Switzerland. On 16 November 2026 that is 47 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 22 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 47 rows: 5 have no round amount, 0 no city and 20 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many series c startups in Switzerland are on the list?
- 47, in the file dated 16 November 2026. 3 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 47 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.